Centre for Community Medicine, All India Institute of Medical Sciences, New Delhi.
Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
J Glob Health. 2020 Jun;10(1):010402. doi: 10.7189/jogh.10.010402.
Influenza causes substantial morbidity and mortality worldwide, however, reliable burden estimates from developing countries are limited, including India. We aimed to quantify influenza-associated mortality for India utilizing 2010-2013 nationally representative data sources for influenza virus circulation and deaths.
Virological data were obtained from the influenza surveillance network of 10 laboratories led by National Institute of Virology, Pune covering eight states from 2010-2013. Death data were obtained from the nationally representative Sample Registration System for the same time period. Generalized linear regression with negative binomial distribution was used to model weekly respiratory and circulatory deaths by age group and proportion of specimens positive for influenza by subtype; excess deaths above the seasonal baseline were taken as an estimate of influenza-associated mortality counts and rates. Annual excess death rates and the 2011 India Census data were used to estimate national influenza-associated deaths.
Estimated annual influenza-associated respiratory mortality rates were highest for those ≥65 years (51.1, 95% confidence interval (CI) = 9.2-93.0 deaths/100 000 population) followed by those <5 years (9.8, 95% CI = 0-21.8/100 000). Influenza-associated circulatory death rates were also higher among those ≥65 years (71.8, 95% CI = 7.9-135.8/100 000) as compared to those aged <65 years (1.9, 95% CI = 0-4.6/100 000). Across all age groups, a mean of 127 092 (95% CI = 64 046-190,139) annual influenza-associated respiratory and circulatory deaths may occur in India.
Estimated influenza-associated mortality in India was high among children <5 years and adults ≥65 years. These estimates may inform strategies for influenza prevention and control in India, such as possible vaccine introduction.
流感在全球范围内导致了大量的发病率和死亡率,但包括印度在内的发展中国家可靠的负担估计数据有限。我们旨在利用 2010-2013 年全国流感病毒循环和死亡的代表性数据源,量化印度的流感相关死亡率。
病毒学数据来自由浦那国家病毒学研究所领导的 10 个实验室的流感监测网络,该网络覆盖了 2010-2013 年的 8 个州。同期的死亡数据来自全国代表性的样本登记系统。采用负二项分布广义线性回归模型,按年龄组和流感亚型阳性标本比例对每周呼吸和循环死亡进行建模;季节性基线以上的超额死亡被视为流感相关死亡人数和比率的估计。利用年度超额死亡率和 2011 年印度人口普查数据,估算全国流感相关死亡人数。
估计的每年流感相关呼吸道死亡率最高的是≥65 岁的人群(51.1,95%置信区间(CI)= 9.2-93.0/100000 人),其次是<5 岁的人群(9.8,95%CI= 0-21.8/100000 人)。与<65 岁的人群相比,≥65 岁的人群流感相关循环死亡率也较高(71.8,95%CI= 7.9-135.8/100000 人)。在所有年龄组中,印度每年可能有 127092 例(95%CI=64046-190013)流感相关呼吸道和循环死亡。
印度的流感相关死亡率在<5 岁的儿童和≥65 岁的成年人中较高。这些估计可能为印度的流感预防和控制策略提供信息,例如可能的疫苗接种。